Global Chloroquine Market Size To Worth USD 114.05 Million By 2033 | CAGR of 2.95%
Category: HealthcareGlobal Chloroquine Market Size To Worth USD 114.05 Million By 2033
According to a research report published by Spherical Insights & Consulting, the Global Chloroquine Market Size is Expected to Grow from USD 85.27 Million in 2023 to USD 114.05 Million by 2033, at a CAGR of 2.95% during the forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 276 pages with 110 Market data tables and figures & charts from the report on the "Global Chloroquine Market Size, Share, and COVID-19 Impact Analysis, By Dosage Form (Injections, Tablets, and Capsules), By Application (Lupus Erythematosus, Malaria, Rheumatoid Arthritis, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here:https://www.sphericalinsights.com/reports/chloroquine-market
The chloroquine market involves the development, production, and distribution of chloroquine, an alkaloid natural product derived from quinine, used to prevent and treat malaria. Chloroquine prevents the polymerization of heme into hemozoin, a food source for the malarial parasite, and functions as an anti-autoimmune therapy by binding to transcriptional factors on T helper 17 cells. It is currently administered orally for malaria prophylaxis and chronic autoimmune disease treatment. Government initiatives, such as the National Framework for Malaria Elimination in India and the National Strategic Plan for Malaria, have led to increased demand for antimalarial medications like chloroquine. Key measures include disease management, integrated vector management, and supportive interventions focusing on behaviour change communication, inter-sectoral convergence, and human resource development through capacity building. The rising prevalence of malaria, as reported by the World Health Organization, is driving the market expansion. The growing number of clinical trials examining chloroquine's effectiveness in treating various diseases could significantly promote its application and market growth. However, alternative anti-malarial medications limit the market growth.
The capsules segment held the largest share of 36.11% in 2023 and is predicted to grow at a significant CAGR during the predicted period.
Based on the dosage form, the global chloroquine market is categorized as injections, tablets, and capsules. Among these, the capsules segment held the largest share of 36.11% in 2023 and is predicted to grow at a significant CAGR during the predicted period. The growth of the segment is attributed to improved bioavailability, rapid absorption, patient compliance, administration ease, accurate dosing, targeted formulations, efficacy, stability, taste masking, and biocompatibility.
The malaria segment accounted for the highest market share of 64.42% in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the application, the global chloroquine market is categorized as lupus erythematosus, malaria, rheumatoid arthritis, and others. Among these, the malaria segment accounted for the highest market share of 64.42% in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. The extensive use of chloroquine in the treatment of malaria is thought to be the cause of the segmental enlargement. The first-line treatment for malaria is chloroquine, and the prevalence of malaria is rising as a result of unsanitary conditions, which increase the formation of the malarial species.
Asia Pacific is expected to hold the greatest share of the global chloroquine market over the forecast period.
Get more details on this report -
Asia Pacific is expected to hold the greatest share of the global chloroquine market over the forecast period. This is ascribed to high malaria prevalence, increased healthcare infrastructure investments, and increased awareness of Chloroquine's prophylactic benefits. Countries like India and Southeast Asia are contributing significantly to this growth, driven by improvements in healthcare infrastructure, increased accessibility to antimalarial medications, and rural healthcare service expansion.
North America is predicted to hold the fastest-growing region of the global chloroquine market throughout the estimated period. The region's market growth is fueled by robust healthcare infrastructure and high malaria prevention awareness, driven by travelers and autoimmune disorders. The rising prevalence of rheumatoid arthritis and lupus supports this demand. Advanced healthcare systems and strong regulatory frameworks facilitate chloroquine availability, and research and development initiatives explore new therapeutic applications.
Major key players in the global chloroquine market are Novartis AG, Cadila Healthcare Ltd, Mylan NV, Teva Pharmaceuticals Ltd., Abcam Plc, Sanofi, Sun Pharmaceuticals Ltd., GlaxoSmithKline plc, Cipla Inc., Bayer AG, AstraZeneca, Ipca Laboratories Ltd., and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In July 2024, GlaxoSmithKline plc and Medicines for Malaria Venture launched the first single-dose medicine for preventing Plasmodium vivax (P. vivax) malaria relapse, tafenoquine, co-administered with chloroquine for radical cure, in Thailand and Brazil. This drug is part of malaria elimination efforts, as P. vivax is the dominant parasite in most countries outside sub-Saharan Africa and is characterized by clinical relapses.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global chloroquine market based on the below-mentioned segments:
Global Chloroquine Market, By Dosage Form
- Injections
- Tablets
- Capsules
Global Chloroquine Market, By Application
- Lupus Erythematosus
- Malaria
- Rheumatoid Arthritis
- Others
Global Chloroquine Market, By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?